Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.150
+0.010 (0.88%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Enzo Biochem Revenue

Enzo Biochem had revenue of $8.02M in the quarter ending April 30, 2024, with 7.17% growth. This brings the company's revenue in the last twelve months to $33.34M, down -204.05% year-over-year. In the fiscal year ending July 31, 2023, Enzo Biochem had annual revenue of $31.06M, down -4.85%.

Revenue (ttm)
$33.34M
Revenue Growth
-204.05%
P/S Ratio
12.53
Revenue / Employee
$24,847
Employees
190
Market Cap
59.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jul 31, 202331.06M-1.58M-4.85%
Jul 31, 202232.64M-85.09M-72.27%
Jul 31, 2021117.73M41.71M54.87%
Jul 31, 202076.02M-5.15M-6.34%
Jul 31, 201981.17M-19.84M-19.64%
Jul 31, 2018 Pro Pro Pro
Jul 31, 2017 Pro Pro Pro
Jul 31, 2016 Pro Pro Pro
Jul 31, 2015 Pro Pro Pro
Jul 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 53.55M
LENSAR 44.50M
Cryo-Cell International 31.64M
ProPhase Labs 28.72M
Adlai Nortye 5.00M
VolitionRx 797.03K
Revenue Rankings